Portal hypertension is the haemodynamic abnormality associated with the most severe complications of cirrhosis, including ascites, hepatic encephalopathy and bleeding from gastroesophageal varices. Variceal bleeding is a medical emergency associated with a mortality that, in spite of recent progress, is still in the order of 10–20% at 6 weeks. The evaluation of diagnostic tools and the design and conduct of good clinical trials for the treatment of portal hypertension have always been difficult. Awareness of these difficulties has led to the organisation of a series of consensus meetings. The first one was organised by Andrew Burroughs in Groningen, the Netherlands in 1986 . After Groningen, other meetings followed, in Baveno, Italy in 1990 (Baveno I) , and in 1995 (Baveno II)  and , in Milan, Italy in 1992 , in Reston, U.S.A.  in 1996, in Stresa, Italy, in 2000 (Baveno III)  and , again in Baveno in 2005 (Baveno IV)  and , in Atlanta in 2007 , and again in Stresa in 2010 (Baveno V)  and . The aims of these meetings were to develop definitions of key events in portal hypertension and variceal bleeding, to review the existing evidence on the natural history, the diagnosis and the therapeutic modalities of portal hypertension, and to issue evidence-based recommendations for the conduct of clinical trials and the management of patients. All these meetings were successful and produced consensus statements on some important points, although several issues remained unsettled. To continue the work of the previous meetings, a Baveno VI workshop was held on April 10–11, 2015. The workshop was attended by many of the experts responsible for most of the major achievements of the last years in this field. Many of them had attended the previous meetings as well.
|Titolo:||Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension|
|Data di pubblicazione:||2015|
|Appartiene alla tipologia:||01a Articolo in rivista|